Chinese quantitative hedge fund managers are increasing investments in their own products, with 25 private fund firms committing more than RMB1.4bn ($195m) since the beginning of July, as managers seek to demonstrate confidence in their strategies and reassure investors during a period of heightened market volatility.
One of the largest commitments came from Ningbo Alpha2Fund Investment Management Partnership, which said it would invest RMB100 million ($14m) of proprietary capital into its own private securities funds.
The Beijing-based quantitative manager said the investment reflected its confidence in the long-term prospects of China’s capital markets and its intention to share both the risks and potential returns of its strategies alongside external investors.
Alpha2Fund was established in 2015 and uses data-driven and algorithmic approaches across its investment strategies. The firm reported more than RMB55 billion in assets under management as of July 2026.
The latest wave of manager self-investment has involved a number of prominent quantitative and private fund firms.
X-Square Investment and Shiva Fund, together with its manager Liang Hong, were among the first to announce commitments in July, investing RMB10m and RMB42m respectively.
Lingjun Investment subsequently committed RMB200m on 19 July, while Longqi Scientific Investment made the month’s largest disclosed commitment the following day, pledging RMB280m.
Other managers, including Youmeili Fund, QianYan Fund, Aquajade Fund and Mengxi Investment, also announced proprietary investments during the month.
The combined commitments represent a significant increase in managers putting their own balance sheets behind the products they offer to outside investors.
For quantitative hedge funds, the move can serve two purposes. Beyond signalling conviction in their models and longer-term return potential, managers can use proprietary investments to demonstrate alignment with clients at a time when volatility and performance drawdowns can increase redemption pressure.
Industry observers said the buying spree reflects both strategic and tactical considerations. Managers may view current valuations as attractive opportunities for deploying capital over a longer investment horizon, while simultaneously using fresh commitments to bolster investor confidence and discourage withdrawals during periods of market stress.
The trend also highlights the increasingly important role of alignment between Chinese private fund managers and their investors. By committing their own capital to the same products, managers are effectively increasing their exposure to the same market risks faced by clients.
For investors, the willingness of managers to invest alongside them may provide additional reassurance, particularly for quantitative strategies where confidence in models and the ability to withstand short-term performance volatility are critical.
